Cytokinetics (CYTK) Misses Q1 EPS by 2c
Tweet
Share
E-mail
Get Alerts CYTK Hot Sheet
Price: $68.78 -1.63%
Revenue Growth %: +1,966.3%
Financial Fact:
Total revenues: 59.05M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +1,966.3%
Financial Fact:
Total revenues: 59.05M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Cytokinetics (NASDAQ: CYTK) reported Q1 EPS of ($1.67), $0.02 worse than the analyst estimate of ($1.65). Revenue for the quarter came in at $19.35 million versus the consensus estimate of $8.59 million.
For earnings history and earnings-related data on Cytokinetics (CYTK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- U.S. and Denmark close in on a Greenland deal - Reuters
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Ximen Mining launches $350,000 bridge placement for Kenville mine
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
